A Case of Neuroretinitis following Inactivated Virion COVID-19 Vaccination

ABSTRACT

Purpose

We report a rare presentation of neuroretinitis following vaccination with inactivated virion vaccine (COVAXIN).

Methods

Interventional Case Report.

Observation

A 14-year-old female presented with sudden unilateral vision loss 3 days following COVID-19 vaccination. The clinical and radiological evaluation was consistent with classical neuroretinitis; the serological and immunological workup was negative. The patient responded well to the pulse steroid therapy and regained complete vision.

Conclusion

The COVID-19 vaccine related adverse ocular events are beginning to emerge slowly and thus warrants close monitoring of all such cases. Also, ophthalmologists should be encouraged to seek vaccination status of patients presenting with inflammatory ocular conditions.

KEYWORDS:

• COVID-19
• inactivated virion
• neuroretinitis
• steroids
• vaccine

Disclosure statement

The authors declare that they have no conflicts of interest.

Ethics declaration

The study adhered to the tenets of Declaration of Helsinki. An informed written consent has been obtained from the patient.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.